Find Comparable Stocks for Sanofi
Sanofi
SNY - NMSSanofi, a healthcare company, is engaged in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company is headquartered in Paris, France.
Income Statement
Financial Ratios
Growth
Abbott Laboratories
ABT - NYQAbbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
Sanofi is a global healthcare leader that develops and markets medicines, paralleling Abbott's focus on pharmaceuticals and healthcare products.
correlation
Measures how closely the two stocks' prices move together over time. A high correlation suggests similar market reactions and investor sentiment.
Pearson Correlation: 27%
R-squared: 7%
This indicates a negligible relationship between the price movements of these stocks.
network
Evaluates the overlap in business networks, partnerships, and industry relationships, indicating similarity in market positioning and competitive landscape.
- Common comparables: 5
- ABT in SNY's comparables: No
- SNY in ABT's comparables: Yes
A high score suggests the companies are often compared to each other and share many industry peers, indicating similar competitive environments and market perceptions.
financials
Compares key financial metrics to assess operational similarity and financial health.
- Revenue Growth: 7% vs -3%
- Profit Margin: 32% vs 13%
- ROE: 31% vs 7%
- Operating Margin: 19% vs 14%
- Revenue (TTM): $41.9B vs $44.3B
A high score indicates similar financial performance, efficiency, and growth trajectories, suggesting comparable business models and market positions.
size
Evaluates similarity in market capitalization, which can indicate comparable market influence, investor interest, and resource availability.
Market Cap: $233.1B vs $149.0B
Size Category: Mega Cap vs Large Cap
A high score suggests the companies are in the same size category, facing similar challenges and opportunities in terms of market presence and financial flexibility.
valuation
Compares valuation metrics to assess if the stocks are valued similarly by the market, indicating comparable investor expectations and perceived growth potential.
- P/E Ratio: 17.59 vs 25.50
- P/B Ratio: 5.01 vs 1.80
- EV/EBITDA: 22.77 vs 13.27
- Forward P/E: 26.74 vs 13.46
- PEG Ratio: 2.47 vs 1.24
A high score indicates that the market values these companies similarly relative to their financials, suggesting comparable growth expectations and risk profiles.
sector
Compares the sector and industry classification of both companies, allowing for partial matches.
- Sector: LIFE SCIENCES vs LIFE SCIENCES
- Industry: PHARMACEUTICAL PREPARATIONS vs PHARMACEUTICAL PREPARATIONS
A high score indicates that the companies operate in similar business areas, facing comparable market conditions, regulatory environments, and industry trends. Partial matches are considered for more nuanced comparisons.
analyst ratings
Compares the consensus of analyst opinions on both stocks.
- ABT Rating: Buy
- SNY Rating: Buy
A high score suggests that analysts view both stocks similarly in terms of their future prospects and investment potential.
geo
Evaluates the geographical similarity of the companies based on country, currency, exchange, and address.
- ABT Country: USA
- SNY Country: USA
- Currency: USD vs USD
- Exchange: NYQ vs NMS
A high score indicates that both companies operate in similar geographical markets, facing comparable economic conditions, regulations, and market dynamics.
volatility
Compares price volatility and risk profiles, indicating similarity in market behavior, risk, and potential for price swings.
- ABT Beta: 0.69 (Low)
- SNY Beta: 0.46 (Low)
A high score suggests both stocks have similar sensitivity to market movements, implying comparable risk levels and potential for both gains and losses.
business similarity
Assesses the similarity of the companies' business models, products, and services.
This score is based on an analysis of the companies' business descriptions, major products, and revenue streams.
A high score indicates that the companies have similar core businesses, target markets, and revenue generation strategies.
momentum
Compares recent price momentum, showing similarity in short-term market performance and investor sentiment.
- ABT Price vs 200-day MA: 117.70%
- SNY Price vs 200-day MA: 114.51%
A high score indicates both stocks are experiencing similar price trends relative to their recent history, suggesting comparable market enthusiasm or concern.
dividend
Compares dividend policies, showing similarity in shareholder return strategies and income potential for investors.
- ABT Dividend Yield: 2%
- SNY Dividend Yield: 3%
A high score indicates similar approaches to returning capital to shareholders, suggesting comparable appeal to income-focused investors.
Income Statement
Financial Ratios
Growth
Loading comparable stocks ...
Abbott Laboratories
ABT - NYQAbbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace...
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.